As a fully integrated design and development firm specializing in medical diagnostics and technologies, we deliver all the expertise you need to move your COVID-19 / SARS-CoV-2 testing solutions quickly to market – all under one roof. Because of our focused experience in this space, we’re currently working with dozens of companies to translate their novel COVID-19 detection ideas into custom instrumentation or complex consumables ready to meet key milestones to support fundraising efforts or be launched into the IVD-regulated market. To learn how Ximedica’s services can help accelerate your COVID-19 / SARS-CoV-2 Dx solutions, please contact us.
LexaGene’s MiQLab™, PCR-based, fully automated diagnostic system for quick response to COVID-19 IVD needs.
Instrument-free, one-step, Lateral Flow Assay (LFA) diagnostics kits for SARS-CoV-2.
Rapid, quantitative, point-of-care platform for IVD detection and diagnosis of COVID-19.
CLIA-waived, point-of-care PCR analyzer targeting multiple pathogen genes simultaneously.
Lab-based, real-time, PCR detection system for COVID-19 identification.
Handheld sample-to-answer molecular system for infectious disease detection.
Instrument-free saliva sample collection tube for detection of SARS-CoV-2.